Skip to main content

J&J vaccine results expected by January 21

By BusinessDay  
   January 11, 2021

The preliminary results for Johnson & Johnson’s (J&J) late-stage Covid-19 vaccine trial should be available by January 21 and will then be submitted to the US Food and Drug Administration, according to the protocol chair for the local arm of the trial, Medical Research Council president Glenda Gray.

Full story

Get the latest on healthcare leadership in your inbox.